Healthcare
•3755 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3755)
| Company | Market Cap | Price |
|---|---|---|
|
ALZN
Alzamend Neuro, Inc.
Company's pipeline includes Alzheimer's disease therapeutics (ALZN002) and a focused strategy on Alzheimer's treatment.
|
$7.35M |
$2.38
+1.50%
|
|
ENTO
Entero Therapeutics, Inc.
Adrulipase is a recombinant lipase enzyme produced as a therapeutic for exocrine pancreatic insufficiency, fitting Recombinant Proteins & Enzymes.
|
$7.18M |
$2.96
-36.48%
|
|
EVAX
Evaxion Biotech A/S
Evaxion develops vaccines, including EVX-01 for cancer and multiple infectious-disease vaccine programs.
|
$7.17M |
$5.18
+1.47%
|
|
VSEE
VSee Health, Inc.
Healthcare Services & Facilities; telehealth services delivered to healthcare providers.
|
$7.05M |
$0.45
+4.52%
|
|
BGLC
BioNexus Gene Lab Corp.
VitaGuard MRD is a tumor-naïve liquid biopsy platform used in BGLC's MRNA Scientific diagnostics, defining a liquid biopsy product category.
|
$7.01M |
$3.85
-1.15%
|
|
PCSA
Processa Pharmaceuticals, Inc.
Processa is a oncology-focused biotech developing Next Generation Cancer therapies (NGCs), placing it squarely in Biotech - Oncology.
|
$6.97M |
$3.50
+1.01%
|
|
KTTA
Pasithea Therapeutics Corp.
Pasithea's lead candidate PAS-4.00 is a MEK inhibitor targeting MAPK pathway-driven tumors, aligning with oncology-focused biotech.
|
$6.86M |
$0.93
+0.77%
|
|
PHIO
Phio Pharmaceuticals Corp.
INTASYL is based on RNA interference (siRNA), making RNAi therapeutics a core product/framework.
|
$6.81M |
$1.17
-2.10%
|
|
GBCS
Selectis Health, Inc.
Operational healthcare facilities providing in-patient care aligns with Hospital Services as a proxy for healthcare facility operations.
|
$6.81M |
$2.23
|
|
ICU
SeaStar Medical Holding Corporation
Core product is a blood purification device (SCD) used in critical care to modulate immune response and remove inflammatory mediators, fitting Blood Purification Devices.
|
$6.73M |
$2.38
-1.04%
|
|
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
The company operates a software-driven planning/diagnostic workflow used in radiology/medical imaging, which can be associated with the diagnostic equipment category.
|
$6.70M |
$0.49
+4.26%
|
|
BIXT
Bioxytran, Inc.
MDX Viewer is an FDA-approved diagnostic device that measures tissue oxygenation and provides real-time metabolic insights; a direct product/service Bioxytran provides.
|
$6.67M |
$0.07
|
|
APYP
AppYea, Inc.
AppySleep devices function as medical devices/biometrics for sleep disorders.
|
$6.62M |
$0.01
|
|
NVNO
enVVeno Medical Corporation
The VenoValve is a surgically implanted vascular intervention device, directly produced by NVNO.
|
$6.62M |
$0.37
+8.72%
|
|
RNAZ
TransCode Therapeutics, Inc.
TransCode Therapeutics operates in biotech oncology, developing cancer therapeutics.
|
$6.61M |
$7.80
-1.64%
|
|
ADIL
Adial Pharmaceuticals, Inc.
Lead AUD program is a neuropsychiatric CNS therapeutic, aligning with Neuropsychiatric Drug Development.
|
$6.45M |
$0.28
-3.65%
|
|
CYCN
Cyclerion Therapeutics, Inc.
Cyclerion is centered on neuropsychiatric drug development, specifically an individualized therapy for Treatment Resistant Depression (TRD).
|
$6.44M |
$1.99
+3.11%
|
|
DQWS
DSwiss, Inc.
DQWS provides turnkey OEM/ODM contract manufacturing services for health care, beauty, and nutraceutical products.
|
$6.41M |
$0.04
|
|
CELZ
Creative Medical Technology Holdings, Inc.
CELZ develops autologous/allogeneic cell therapies (ImmCelz and AlloStem), a core cell therapy business.
|
$6.32M |
$2.36
-3.67%
|
|
SYNX
Silynxcom Ltd.
Vital signs monitoring headset positions the product within medical devices/biometric sensing.
|
$6.29M |
$1.20
+0.84%
|
|
PMCB
PharmaCyte Biotech, Inc.
PMCB's encapsulation technology is a drug-delivery platform enabling localized prodrug activation.
|
$6.26M |
$0.94
+2.48%
|
|
LYRA
Lyra Therapeutics, Inc.
XTreo drug-delivery platform is Lyra's core product, enabling six months of localized drug therapy via in-office implant (LYR-210).
|
$6.25M |
$3.89
+2.37%
|
|
SBFM
Sunshine Biopharma, Inc.
SBFM's Nora Pharma operates a growing Canadian generic prescription drug business.
|
$6.24M |
$1.36
-0.73%
|
|
SNOA
Sonoma Pharmaceuticals, Inc.
Company offers HOCl-based wound care products that function as wound care solutions/devices.
|
$6.21M |
$3.73
-1.46%
|
|
HIGR
Hi-Great Group Holding Company
KRAS gene license places HIGR in Biotech - Oncology, an oncology-focused biotech asset.
|
$6.21M |
$0.06
|
|
MODV
ModivCare Inc.
MODV delivers technology-enabled healthcare services (NEMT, PCS, Monitoring) and related care operations, aligning with Healthcare Services & Facilities.
|
$6.19M |
$0.43
|
|
XTLB
XTL Biopharmaceuticals Ltd.
Core focus on autoimmune immunology therapeutics with lead asset hCDR1.
|
$6.18M |
$0.63
-8.84%
|
|
SNGX
Soligenix, Inc.
ThermoVax vaccine thermostabilization platform and RiVax vaccine program place Soligenix in Vaccines.
|
$6.17M |
$1.40
-2.78%
|
|
IBO
Impact BioMedical Inc.
Linebacker is an oncology-focused platform of electrophilically enhanced polyphenol compounds licensed for development and commercialization.
|
$6.17M |
$0.49
-3.12%
|
|
PPCB
Propanc Biopharma, Inc.
Propanc Biopharma is a development-stage biotechnology company focusing on oncology therapies, making PRP its core candidate.
|
$6.15M |
$0.48
-0.81%
|
|
IDXG
Interpace Biosciences, Inc.
Interpace focuses on oncology-focused molecular diagnostics and cancer risk biomarker testing, including thyroid-related cancer risk assessment.
|
$6.14M |
$1.07
|
Showing page 35 of 38 (3755 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
